Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,063.50    -18.50 (-1.71%)
Bid:
1,063.50
Ask:
1,064.50
Spread: 1.00 (0.094%)
Market Cap: £3.41b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Board Change

29 Apr 2020 07:01

RNS Number : 2284L
Persimmon PLC
29 April 2020
 

29 April 2020

 

Persimmon plc

 

Appointment of Annemarie Durbin as Independent Non-Executive Director

 

Persimmon Plc is pleased to announce the appointment of Annemarie Durbin to the Board as an Independent Non-Executive Director with effect from 1 July 2020. Annemarie will also join the Company's Remuneration Committee as Chair, and the Nomination Committee, on the same date.

Annemarie has 30 years broad-based, retail, commercial, corporate and institutional banking experience across Asia, Africa & the Middle East and is an experienced coach and mentor. She spent 20 years at Standard Chartered, the FTSE 100 international bank, in a variety of executive roles across the UK and Asia, culminating in membership of the Group Executive Committee. She has subsequently become a highly Experienced Board Chair, Independent Non-Executive Director and Remuneration Committee Chair.

Annemarie is currently a non-executive director and Remuneration Committee Chair of W H Smith PLC and Santander UK plc, and is non-executive Board Chair of Merryck & Co a leading coaching and mentoring group. She was previously a non-executive director of Ladbrokes Coral Plc.

Roger Devlin, Chairman of Persimmon, said: "Annemarie is a highly experienced international business executive, with a strong background in corporate governance and human resources. Her experience and knowledge will be invaluable to Persimmon as we continue to implement our programme of business improvement. I am pleased to welcome Annemarie to the board."

As noted in the 2019 Annual Report, Marion Sears, who was due to retire as a Non-Executive Director of the Company, and Chair of the Remuneration Committee, at the conclusion of the Annual General Meeting on 29 April 2020, will now remain on the Board until 30 June 2020 to allow time for Annemarie to take up her post.

 

No further information is required to be disclosed pursuant to Listing Rule 9.6.13.

 

For further information, please contact:

Citigate Dewe Rogerson

Simon Rigby / Kevin Smith / Jos Bieneman

Tel: +44 (0)20 7638 9571

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAQVLFLBZLXBBQ
Date   Source Headline
1st May 20257:00 amRNSAGM Trading Statement
25th Apr 202510:54 amRNSHolding(s) in Company
25th Apr 20259:24 amRNSHolding(s) in Company
11th Apr 20254:22 pmRNSHolding(s) in Company
3rd Apr 202510:15 amRNSHolding(s) in Company
2nd Apr 202512:22 pmRNSHolding(s) in Company
1st Apr 202512:03 pmRNSTotal Voting Rights
31st Mar 20253:14 pmRNSDirector/PDMR Shareholding
27th Mar 202510:08 amRNSHolding(s) in Company
25th Mar 20253:14 pmRNSDirector/PDMR Shareholding
24th Mar 20253:35 pmRNSAnnual Report 2024 and Notice of AGM 2025
24th Mar 20252:24 pmRNSHolding(s) in Company
11th Mar 20257:00 amRNSFull Year Results
6th Mar 20252:06 pmRNSHolding(s) in Company
3rd Mar 20253:35 pmRNSHolding(s) in Company
3rd Feb 202512:26 pmRNSTotal Voting Rights
14th Jan 20257:00 amRNS2024 Trading Statement
2nd Jan 20251:00 pmRNSTotal Voting Rights
10th Dec 20243:47 pmRNSDirectorate Change
2nd Dec 20242:11 pmRNSBlock listing Interim Review
2nd Dec 202412:00 pmRNSTotal Voting Rights
6th Nov 20247:00 amRNSQ3 Trading Statement
5th Nov 20241:31 pmRNSHolding(s) in Company
1st Nov 20243:59 pmRNSTotal Voting Rights
1st Oct 20241:19 pmRNSTotal Voting Rights
24th Sep 202412:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20241:44 pmRNSTotal Voting Rights
8th Aug 20247:00 amRNSHalf Year Results
1st Aug 20242:32 pmRNSTotal Voting Rights
23rd Jul 202410:28 amRNSDirectorate Change
1st Jul 20241:10 pmRNSTotal Voting Rights
19th Jun 20242:48 pmRNSDirector/PDMR Shareholding
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.